Novo Nordisk to add more than 600 jobs in U.S. as diabetes grows

Novo Nordisk (NYSE: NVO) said it would add more than 600 jobs across the United States, or 15 percent of its U.S. workforce, to keep up with the growing number of Americans with diabetes. It is a mark…
Read the full story: MedCity News